chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Atrial fibrillation. Around 3 PM on 4/10/2022 I noticed a highly irregular heartbeat while doing some semi-strenuous outdoor activities. I went to an urgent care where nurse recommended I go to emergency department given seriousness of issue. I declined ambulance and drove to Hospital emergency department. Hospital report reads "New onset atrial fibrillation with uncontrolled rate. Hypokalemia".  I was given Cardizem in the ER which "reset" the heart to normal sinus rhythm. It should be noted that I had (1) episode of what I believe was atrial fibrillation prior to the event described above. That episode occurred around February 1, 2022. This happened after strenuous tennis and while I was battling a cold. I did not go to the ER at the time, though in retrospect I should have. This led me to visit a cardiologist. During March 2022 I underwent a series of tests and wore a heart monitor. The doctor did not find any incidents of atrial fibrillation. I underwent an echocardiogram and a stress test. The conclusion was my heart is healthy.
Patient woke up in the middle of the night with a high fever (patient reported 105 F) and very bad chills and shaking.  Patient stated this lasted approximately 5 hours before she was able to get back to sleep.  She reported that the fever and chills had resolved by the following morning at 10:00 AM but she was still feeling tired and fatigued.
PATIENT NOTICED ITCHING ON RIGHT ARM AT INJECTION SITE THE EVENING OF RECIEVING HER VACCINES.  SHE RECIEVED TdaP AND MCV4 IN THE RIGHT ARM AND GARDISIL VACCINE IN THE LEFT ARM.  MOTHER NOTED REDESS AT SITE.  MOTHER NOTED AS DAYS WENT ON THAT THE REDNESS SPREAD.  MOTHER DID NO INTERVENTIONS FOR CHILD.  MOTHER REPORTED TO THE IMMUNIZATIONS CLINIC 27 FEB 2012 AT APPROXIMATELY 12 PM.  I SAW CHILD'S REDNESS ON THE RIGHT ARM.  MOTHER HAD MARKED THE RASH FROM EARLIER TIME TO NOTE THAT THE REDNESS WAS INCREASING.  CHILD PRESENTED WITH NO OTHER S/SX OTHER THAN ITCHING AT SITE.  I REPORTED THE INFORMATION TO THE PEDIATRICS CLINIC IMMEDIATELY.  THE CHILD WAS THEN SEEN BY A PEDIATRICIAN.  THE PEDIATRICIAN SENT THE CHILD HOME WITH HOME CARE.  NO MEDICATIONS PRESCRIBED.
Swelling and soreness in armpit area of right arm. Caused a menstral cycle with heavy bleeding but I am Menopausal and do not get menstral cycles.
9/7/2022 Moderna Monovalent was given not Bivalent. We advised patient in 2 months they can return for a Bivalent shot. Patient tolerated well. No Adverse reactions
This spontaneous report as received from a medical assistant refers to a 12 month old Child patient of unknown gender. The patient's concurrent conditions, medical history, concomitant medications, drug reactions and allergies were not reported. On 20-SEP-2018, the patient was vaccinated with improperly stored dose of VAQTA ped 0.5 ml vial (dose, frequency and route were not reported) (lot # R009953, expiry date: 12-JUN-2019) for prophylaxis. The vaccine was exposed to the temperature of 32.21 degree Fahrenheit (°F) (32F to 35 F) for 3.5 hours from 06-SEP-2018. Previous excursion was 50.37 °F for 4.5 hours as recorded by a data logger. No adverse effect was reported. No product quality complaint was involved. This is one of the several reports received from the same reporter source. Sender's Comments: US-009507513-1809USA002868:Original Case : 1809USA002868; US-009507513-1902USA009324:Original Case : 1902USA009323; US-009507513-1902USA009325:Original Case : 1902USA009323; US-009507513-1902USA009326:Original Case : 1902USA009323.
lymph nodes swelling; This spontaneous case was reported by a consumer and describes the occurrence of LYMPHADENOPATHY (lymph nodes swelling) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced LYMPHADENOPATHY (lymph nodes swelling). At the time of the report, LYMPHADENOPATHY (lymph nodes swelling) outcome was unknown.      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   Relevant concomitant medications were not provided.  Treatment information was not provided.
neuropathy; This case was reported by a consumer via interactive digital media and described the occurrence of neuropathy in a female patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced neuropathy (serious criteria GSK medically significant). On an unknown date, the outcome of the neuropathy was unknown.   The reporter considered the neuropathy to be related to Shingles vaccine.  Additional details were provided as follows: The age at vaccination was not reported. The reporter knew the patient who had terrible reactions to the shingles shot. The reporter stated that the shots had metal in them and caused neuropathy. One of the patient's friend sued and won her case.  lt took 2 years to receive the settlement. This case has been linked with US2021AMR199707, reported by the same reporter.; Sender's Comments:  US-GLAXOSMITHKLINE-US2021AMR199707:Same reporter
Patient experiences lightheadedness and blurred vision after vaccination, blood pressure taken and was 107/64 which the patient was unaware if it was average for her. Patient remained seated for an additional 15 minutes and felt normal after waiting. Pt was also given water. Patient was called at 10:45 to verify information regarding this report and felt "Perfectly normal."
Serious adverse event; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by an other health care professional and describes the occurrence of ADVERSE EVENT (Serious adverse event) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. In September 2020, the patient experienced ADVERSE EVENT (Serious adverse event). At the time of the report, ADVERSE EVENT (Serious adverse event) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
it was rpt by RN p/ being vax w/1st & 2nd dose of vax pt subsequently exp lack of seroconversion.
Hives on the face next morning. Some croupy cough lasting 5 days.
Tdap given in L deltoid. 40 Min. later her L eye was noticibly swollen, but not shut. Given a Benadryl pill and was improved within 30 min. Then her R eye swelled ~45 min later and she received another Benadryl and sent home from school.
My daughter was supposed to receive the updated bivalent booster.  I confirmed the information was correct on the paperwork I signed and also verbally confirmed with the pharmacist administering the shot.  She said she was "absolutely sure" it was the Moderna updated booster.  It was not.  My daughter received the primary Moderna formula.
1.5 inch area of erythema. Raised and warm to touch. Tender. Located on left upper thigh.
dizziness; fatigue; bad body aches; largely swollen lymph node; ear fullness; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 53 year-old female patient received bnt162b2 (BNT162B2), administered in arm left, administration date 18Jan2022 20:00 (Batch/Lot number: unknown) at the age of 53 years as dose 3 (booster), single for covid-19 immunisation. Relevant medical history included: "High blood pressure" (unspecified if ongoing); "cholesterol" (unspecified if ongoing); "anxiety" (unspecified if ongoing); "thyroid issue" (unspecified if ongoing); "environmental allergies" (unspecified if ongoing); "Latex allergy" (unspecified if ongoing), notes: Verbatim: Known allergies: Latex, sulfa drugs, iodine dye; "sulfa allergy" (unspecified if ongoing), notes: Verbatim: Known allergies: Latex, sulfa drugs, iodine dye; "iodine dye allergy" (unspecified if ongoing), notes: Verbatim: Known allergies: Latex, sulfa drugs, iodine dye. Concomitant medication(s) included: LEVOTHYROXINE; SERTRALINE; PRAVASTATIN; ATENOLOL. Vaccination history included: Bnt162b2 (DOSE 2, SINGLE, prev dose lot unknown reason: Not available/provided to reporter at the time of report completion, prev dose administration time: 12:00, prev dose vaccine location: Left arm), administration date: 12Apr2021, when the patient was 52 years old, for COVID-19 immunization; Bnt162b2 (DOSE 1, SINGLE, prev dose lot unknown reason: Not available/provided to reporter at the time of report completion, prev dose administration time: 12:00 , prev dose vaccine location: Left arm), administration date: 03May2021, when the patient was 52 years old, for COVID-19 immunization. The following information was reported: DIZZINESS (non-serious) with onset 19Jan2022 12:00, outcome "recovering", described as "dizziness"; FATIGUE (non-serious) with onset 19Jan2022 12:00, outcome "recovering", described as "fatigue"; PAIN (non-serious) with onset 19Jan2022 12:00, outcome "recovering", described as "bad body aches"; LYMPHADENOPATHY (non-serious) with onset 19Jan2022 12:00, outcome "not recovered", described as "largely swollen lymph node"; EAR DISCOMFORT (non-serious) with onset 19Jan2022 12:00, outcome "recovering", described as "ear fullness". Therapeutic measures were not taken as a result of dizziness, fatigue, pain, lymphadenopathy, ear discomfort.  Additional information: The patient did not receive any other vaccine in four weeks. The patient had not been tested covid-19 post vaccination. The patient had not tested positive covid -19 prior vaccination. 15 hours after first dose booster for Covid 19, the patient had ear fullness, dizziness, bad body aches, largely swollen lymph node under left arm (2 days later and it was still swollen), fatigue.  The lot number for bnt162b2 was not provided and will be requested during follow up.
This case was reported by a healthcare professional via a sales representative and described the occurrence of tachycardia in a 46-year-old male subject who was vaccinated with FLUARIX QUADRIVALENT (GlaxoSmithKline). Concurrent medical conditions included hypertension for which the subject was treated with Antihypertensive (Hypertension med). The subject has received previously flu shot the subject had none document reactions experienced with previous flu shots or any adverse events following previous vaccinations. On 15 September 2014, the subject received 1st dose of FLUARIX QUADRIVALENT (.5 ml, unknown route, right arm). On 15 September 2014, about 2 hours after vaccination with FLUARIX QUADRIVALENT, the subject experienced tachycardia and hypertension aggravated. The subject was treated with TYLENOL and BENADRYL. On 15 September 2014, the events were resolved. The healthcare professional considered the tachycardia was probably related to vaccination with FLUARIX QUADRIVALENT and the hypertension was unrelated to vaccination with FLUARIX QUADRIVALENT. This was one of the 3 reports received from the same field representative, and all 3 subjects were employees of the health system or facility.
Received 4 year vaccines. Approximately 3-5 min following administration noted reported sneezing, copious nasal discharge, red, watery eyes with swelling of eyes and face. Significant itching, face and trunk. Epinephrine 1:1000 0.2ml administered SC. Apical rate 168, B/P 120/60. 911 called and transported.
persistent crying (@ times high pitched) for 24_ hrs p/vax;had start of URI @ time of vax;URI devel into bronchiolitis crying assoc w/pallor & back arching
It has not been determined if the flu shot on 10/15/04 is correlated with patient's current illness. On 10/27/04, clinic was informed that the doctor was requesting information regarding when he had his flu shot. Information provided to infection control per clinic. On 10/28/04, infection control reported patient is currently hospitalized with headache, nausea/vomiting, hypertension, possible migraine symptoms. He has no fever and no localized reaction at injection site (for flu shot) per infection control. Write called VAERS and spoke with HIS who stated the physician can call another phone number to see if the flu shot could have any correlation to the patient's current signs and symptoms which required hospitalization. Called nurse in family practice (no answer) and informed her of the VAERS phone number. Nurse reported she would give this information to the doctor. On 11/02/04, writer emailed doctor inquiring if there is a correlation between flu shot and patient's condition. As of 11/16/04, no response from the doctor. Patient reported to writer on 11/12/04 that he was having trouble with balance and has been falling. Patient states doctor did not think his illness is related to the flu shot he got on 10/15/04. Medical records received on 1/25/2005 states pt experienced dizziness and fatigue. Follow up 03/08/2005: The main syptoms of the adverse event were dinzziness, fatigue and decreased memory that occurred 13 dayas after vaccintation. The patient was diagnosed with subacute vertigo with no evidence of peripheral vestibulopathy. Records mention previous episodes over the past 3 to 4 months but worse now. Follow up 02/11/05: The employee health does not have any updates, please contact patient's physician.
Swelling, tenderness, redness, and warmth at injection site. The affected area is progressively getting bigger.
During the process of vaccinating the client with HPV, she became pale, diaphoretic and non compliant to verbal orders. Cold water compress was applied to neck and face, Vital signs were obtained. Patient was given orange juice prior to immunizations after admitting not eating that A.M. A second can of orange juice was given after patient bacame more responsive. Patient was walked to alternate room and allowed to lie down until she felt better. Patient left with Guardian under own power.
Major increase in tinitus. I never had this before vaccinating for covid. After second dose I began having mild tinitus. Now, after the booster, the sound has increased substantially and is constant.
shortness of breath; soft stool; diarrhea; runny nose; constant sneezing; gastro-intestinal issues; This spontaneous case was reported by a consumer and describes the occurrence of DYSPNOEA (shortness of breath), FAECES SOFT (soft stool), DIARRHOEA (diarrhea), RHINORRHOEA (runny nose) and SNEEZING (constant sneezing) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. #045B21A and 039A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Diverticulosis, Thyroid disorder and Diabetes.   On 02-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced DYSPNOEA (shortness of breath), FAECES SOFT (soft stool), DIARRHOEA (diarrhea), RHINORRHOEA (runny nose), SNEEZING (constant sneezing) and ABDOMINAL DISCOMFORT (gastro-intestinal issues). The patient was treated with PARACETAMOL (TYLENOL) for Pain, at a dose of 1 dosage form once a day. At the time of the report, DYSPNOEA (shortness of breath), FAECES SOFT (soft stool), DIARRHOEA (diarrhea), RHINORRHOEA (runny nose), SNEEZING (constant sneezing) and ABDOMINAL DISCOMFORT (gastro-intestinal issues) outcome was unknown.            The patient's concomitant medication included thyroid medication and diabetes medication. Treatment medication included medication for diarrhea Action taken with mRNA-1273 in response to the event was not applicable.   This case was linked to MOD-2021-116349, MOD-2021-116401 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 23-Jul-2021: Medical history - Diverticulitis, New events added.
Menstruation about 2 weeks after injection was a spot of blood for a total of 5 days
2hrs after the vaccination -slight headache and nauseated Noticed the redness/ stiffness of the area  1/01/2021 and lasted 3days
This spontaneous report as received from a pharmacist refers to a patient of unknown age and gender. No concurrent condition, medical history or allergy/drug reactions were reported. On 24-OCT-2015 00:00, the patient was vaccinated with improperly stored RECOMBIVAX HB with lot number, expiry date, dose and strength unspecified. No concomitant medications were reported. No adverse effects were reported. The high temperature and low temperature were 4.1 and -4.6 (17hours 46 mins) respectively. There were no product quality complaints (PQC) involved. No additional information was provided. This is one of the several reports from the same reporter. Additional information has been requested.
MARKED LOCAL ERYTHEMA AND TENSE EDEMA W/ TENDERNESS, BUT NO INFECTION NOTED AROUND INJECTION SITE -- MODERATE SEVERITY, LOCAL IMMUNE REACTION 3 DAYS POST-VACCINE.  TREATED W/ NSAIDS AND COOL COMPRESS.
The next day after administration I had chills and a fever of 100.8 with rhinitis, aches and pains.  It lasted until the followig morning when my temp returned to nomal by noon.
10-15-2015 my left arm itchy - took off band aid on 10/15/15 and noticed small ulcer that has scabbed over never had rxn like this before - (L) deltoid heavy and sore for couple days.
pain at injection site; Fever; Fatigue; Dizziness/lightheadedness; Difficulty reading; Chills; I experienced side effects of headache, fatigue, fever, chills, difficulty reading/slow to comprehend, dizziness/lightheadedness, pain at injection site, loss of appetite, and swollen lymph nodes in n; Swollen lymph nodes in neck; Loss in appetite; This is a spontaneous report from a contactable consumer, the patient. A 34-year-old non-pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6199), dose number 2, via an unspecified route of administration in the left arm on 14Mar2021 at 09:45 (at the age of 34-year-old at vaccination) as a single dose for COVID-19 vaccination. Medical history and concomitant medications of the patient were not reported. The patient did not have allergy to medications, food or other products. Past drug history of the patient included BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6201), dose number 1, via an unspecified route of administration in the left arm on 20Feb2021 (at the age of 34-year-old at vaccination) as a single dose for COVID-19 vaccination. The patient did not receive any other vaccines within 4 weeks prior to vaccination. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination the patient has not been tested for COVID-19. On 14Mar2021 at 18:00, the patient experienced side effects of headache, fatigue, fever, chills, difficulty reading/slow to comprehend, dizziness/lightheadedness, pain at injection site, loss of appetite and swollen lymph nodes in neck. The patient recovered from headache, fever/chills, swollen nodes, site pain and body aches within 48 hours but the difficulty reading and comprehending and dizziness/ lightheadedness remained. Dehydration was not an issue as the patient drank bottle of water every 2 hours. The patient found herself needing to hold a railing when on stairs and move slowly when getting up and walking. No therapeutic measures were taken for the event. The outcome of the events were recovered with sequel at an unknown date and the events difficulty reading and dizziness was not recovered at the time of this report. No follow-up attempts are possible. No further information is expected.
About 4 hours after vaccine arm very sore 3/4" swelling at site. Arm hurt bad enough he couldn't make a fist. 10/26/05 today it's ok a little sore but can move it. Patient stated " this was a second dose". No treatment sought. Used ice pack & Tylenol.  10/18/99 #1pneumoccocal vaccine.
Swelling, pain, heat, redness at injection site, shaking and nausea (lasted about 15 mins).
Pt recv vax on 1/26/98( 6 mo PREGNANT); on 1/27/98 pt exp vaginal spotting; pt seen by obstetrician; tx=no lifting
Systemic: Allergic: Rash (specify: facial area, extremeties)-Medium, Systemic: Allergic: Rash Generalized-Medium
Patient was vaccinated at 11:06 AM with Pfizer vaccine then headed out to the observation area to sit for  30 minutes.  At approx 11:45 AM, Patient s/w  observer medical staff and  c/o throat tightness.  She was then moved to another area for further assessment while 911 was called. Nurse and Dr.  stayed with patient until paramedics arrived at approx 11:48 AM. Patient was triaged by Paramedics then transported to  Emergency Department at 11:55 AM.  Patient was assessed and found not to be having an adverse event but possibly anxiety expisode.  Patient was released to go home at 12:55 PM.
At around 10 pm 7 days after receiving my first dose, I noticed a lump in my left upper arm near but not exactly at the point of injection. It quickly swelled to the size of a golfball and was painful, like a sore muscle. The following day the swelling had gone down somewhat but the area was itchy and slightly red. Two days out, the swelling and itchiness are nearly gone.